I completely agree. But this where hindsight and context are important. If COVID hadn't have happened and instead of bringing manufacturing back to the US pharma companies decided to ship more MF overseas, then we would have said MCS and the new plant was a bad idea. Just like everyone says Scott's decision to buy TEVA portfolio was a terrible decision, it is only a bad decision in hindsight given a change in the environment. Nobody gets every decision right. You just hope that the good outweigh the bad. My belief is that once Nuvaring and E4 are approved and commercialized, everyone will be singing SR's praises and nobody will remember TEVA (except for us lonely few long time holders of course!). In other news, I think we are very close to Nuvaring approval now... anytime Aug-Oct by my calculations. Bring it on.
MYX Price at posting:
41.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)